2020's IPO party continues with four new Nasdaq entrants, including Covillionaire Carl Hansen's AbCellera
Three more companies are making their Wall Street debuts Friday as the industry’s record-breaking IPO year nears a conclusion, with two massive raises in the group — including the newest Covillionaire’s outfit.
The biotechs AbCellera, 4D Molecular Therapeutics and Nanobiotix, as well as biosimulation company Certara, all priced late Thursday. Certara raised the most of the bunch at a whopping $668 million, while Carl Hansen’s AbCellera neared the half-billion mark at $483 million. 4DMT raised $193.2 million in its second IPO go-around, and Nanobiotix followed up with a $99 million raise of their own.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.